Howard J. Weinstein

Pediatrics
55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08.

Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08.

Journal: Blood
Published: April 11, 2025

Dose-dense chemotherapy enables elimination of RT for the majority of low-risk pediatric Hodgkin lymphomas: PHC study HOD08.

Dose-dense chemotherapy enables elimination of RT for the majority of low-risk pediatric Hodgkin lymphomas: PHC study HOD08.

Journal: Blood
Published: April 11, 2025

Self-Reported Quality of Life and Lived Experiences of Adolescent Cancer Survivors Aged 10-19 in Southwestern Uganda: A Mixed-Methods Study in a Resource-Limited Setting.

Self-Reported Quality of Life and Lived Experiences of Adolescent Cancer Survivors Aged 10-19 in Southwestern Uganda: A Mixed-Methods Study in a Resource-Limited Setting.

Journal: Cancer reports (Hoboken, N.J.)
Published: September 26, 2024

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90.

Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90.

Journal: Blood advances
Published: June 12, 2023

"Money was the problem": Caregivers' self-reported reasons for abandoning their children's cancer treatment in southwest Uganda.

"Money was the problem": Caregivers' self-reported reasons for abandoning their children's cancer treatment in southwest Uganda.

Journal: Pediatric blood & cancer
Published: April 13, 2021

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.

Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.

Journal: British journal of haematology
Published: August 18, 2018

Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia.

Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia.

Journal: Pediatric blood & cancer
Published: June 15, 2018

Using Physician-Level Emergency Department Utilization Reports to Address Avoidable Visits by Patients Managed by Pediatric Specialists.

Using Physician-Level Emergency Department Utilization Reports to Address Avoidable Visits by Patients Managed by Pediatric Specialists.

Journal: Hospital pediatrics
Published: October 22, 2017

Facial manifestations of Epstein-Barr virus-related lymphoproliferative disease in childhood acute lymphoblastic leukemia in remission: Two atypical presentations.

Facial manifestations of Epstein-Barr virus-related lymphoproliferative disease in childhood acute lymphoblastic leukemia in remission: Two atypical presentations.

Journal: Pediatric blood & cancer
Published: March 18, 2016

Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography.

Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography.

Journal: World journal of radiology
Published: September 30, 2015

Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.

Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.

Journal: British journal of haematology
Published: December 09, 2014

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.

Journal: British journal of haematology
Published: April 16, 2014
Showing 1-12 of 21

Last Updated: 09/26/2026